Zhu-jian H. Deng
Nanning, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Sintilimab as adjuvant therapy for high-risk hepatocellular carcinoma after curative resection: a multicentric retrospective cohort study.
Journal: European journal of gastroenterology & hepatology
Published: July 01, 2025
Tertiary lymphoid structures in HCC: Influence on immune cell profiles in tumors and on efficacy of adjuvant PD-1 inhibitor therapy after hepatectomy.
Journal: Hepatology (Baltimore, Md.)
Published: March 07, 2025
Neoadjuvant transarterial chemoembolization with tyrosine kinase and immune checkpoint inhibitors improves survival from resectable hepatocellular carcinoma in a multicenter, retrospective study (GUIDANCE002).
Journal: Communications medicine
Published: February 05, 2025
Treatment Duration of Adjuvant Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Patients at High Risk of Recurrence after Resection: A Prospective, Multicentric Cohort Study.
Journal: Liver cancer
Published: September 02, 2024
lncSNHG16 promotes hepatocellular carcinoma development by inhibiting autophagy.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: August 02, 2024
Prevalence of metabolic syndrome among patients with hepatocellular carcinoma of different etiologies: a retrospective study.
Journal: Infectious agents and cancer
Published: January 02, 2024
Deep learning of pretreatment multiphase CT images for predicting response to lenvatinib and immune checkpoint inhibitors in unresectable hepatocellular carcinoma.
Journal: Computational and structural biotechnology journal
Published: December 14, 2023
miR-17-5p slows progression of hepatocellular carcinoma by downregulating TGFβR2.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: January 27, 2023
Second-line treatment options for hepatocellular carcinoma: current state and challenges for the future.
Journal: Expert opinion on investigational drugs
Published: November 28, 2022
Prognosis after hepatic resection of patients with hepatocellular carcinoma related to non-alcoholic fatty liver disease: meta-analysis.
Journal: BJS open
Published: October 07, 2022
Last Updated: 09/26/2026